We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Magnetic Nanoparticles for Detecting Cancer

By Biotechdaily staff writers
Posted on 18 Sep 2005
Researchers have designed highly magnetized nanoparticles based on metallic iron that could soon be used in a non-invasive therapy for cancer in which treatment would begin at the time of detection.

"We envision a potential for these materials to combine both detection and treatment into a single process,” said Everett E. More...
Carpenter, Ph.D., an assistant professor of chemistry at Virginia Commonwealth University (VCU; Richmond, USA). Dr. Carpenter and coworkers are trying to determine how to best construct the core-shell structure and figure out which shell compounds are most suited for biomedical applications such as magnetodynamic therapy (MDT), or as magnetic resonance imaging (MRI) contrast enhancement agents.

According to Dr. Carpenter, in the future it may be possible for a patient to be screened for breast cancer using MRI methods with engineered enhanced ferrites as the MRI contrast agent. He said if a tumor is identified, the clinician could then increase the power to the MRI coils and localized heating would destroy the tumor site without damaging the surrounding healthy cells.

Another promising biomedical tool is MDT, which utilizes magnetic nanoparticles that are combined with the radiofrequency waves of MRI. This coupling changes the radiofrequency into heat energy that kills the cancer cells. European researchers studying MDT have shown that nanoparticles are able to target tumor cells. Dr. Carpenter reported that because the nanoparticles target tumor cells and are substantially smaller than human cells, only the very few tumor cells next to the nanoparticles are killed, which greatly minimizes damage to healthy cells.

Enhanced ferrites are a group of ferrites that are specifically modified to have enhanced magnetic or electrical characteristics and are created through the use of core-shell morphology. According to Dr. Carpenter, with this approach the core can be a highly magnetic material such as iron or iron alloys, whereas the shell can be a mixed metal ferrite with customized resistivity. Dr. Carpenter said that the high magnetization of the enhanced ferrite nanoparticles may potentially improve the absorption of the radiofrequency waves, thereby providing optimal identification of tumor sties and the use of less MRI contrast agents.

In 2002, Carpenter created a new material based on metallic iron. He said the magnetic power of the iron nanoparticles he invented is 10 times greater than that of the currently available iron oxide nanoparticles, which translates to a considerable decrease in the amount of iron needed for imaging or therapy.




Related Links:
Virginia Commonwealth University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.